Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$56.95+1.58 (+2.85%)
Close on Nov 18, 2026Market cap $3.40BP/E –Yield –
Axogen revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Axogen's revenue for the twelve months ending Sep 30, 2026 was $266.93M, up 24.3% year over year. For fiscal 2025 it was $225.21M, up 20.2% from the year before. Over ten years it grew 23.5% a year on average. The highest annual figure on record is $225.21M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $225.21M | +20.2% |
| FY2024 | Dec 31, 2024 | $187.34M | +17.8% |
| FY2023 | Dec 31, 2023 | $159.01M | +14.7% |
| FY2022 | Dec 31, 2022 | $138.58M | +8.8% |
| FY2021 | Dec 31, 2021 | $127.36M | +13.4% |
| FY2020 | Dec 31, 2020 | $112.30M | +5.2% |
| FY2019 | Dec 31, 2019 | $106.71M | +27.1% |
| FY2018 | Dec 31, 2018 | $83.94M | +38.9% |
| FY2017 | Dec 31, 2017 | $60.43M | +47.0% |
| FY2016 | Dec 31, 2016 | $41.11M | +50.4% |
| FY2015 | Dec 31, 2015 | $27.33M | +62.5% |
| FY2014 | Dec 31, 2014 | $16.82M | +53.6% |
| FY2013 | Dec 31, 2013 | $10.95M | +42.3% |
| FY2012 | Dec 31, 2012 | $7.69M | +58.6% |
| FY2011 | Dec 31, 2011 | $4.85M | +61.4% |
| FY2010 | Dec 31, 2010 | $3.00M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $75.83M | +26.2% |
| Q2 FY2026 | Jun 30, 2026 | $69.73M | +23.1% |
| Q1 FY2026 | Mar 31, 2026 | $61.46M | +26.6% |
| Q4 FY2025 | Dec 31, 2025 | $59.90M | +21.3% |
| Q3 FY2025 | Sep 30, 2025 | $60.08M | +23.5% |
| Q2 FY2025 | Jun 30, 2025 | $56.66M | +18.3% |
| Q1 FY2025 | Mar 31, 2025 | $48.56M | +17.4% |
| Q4 FY2024 | Dec 31, 2024 | $49.41M | +15.1% |
| Q3 FY2024 | Sep 30, 2024 | $48.64M | +17.9% |
| Q2 FY2024 | Jun 30, 2024 | $47.91M | +25.6% |
| Q1 FY2024 | Mar 31, 2024 | $41.38M | +12.9% |
| Q4 FY2023 | Dec 31, 2023 | $42.92M | +18.7% |
| Q3 FY2023 | Sep 30, 2023 | $41.27M | +11.7% |
| Q2 FY2023 | Jun 30, 2023 | $38.16M | +10.7% |
| Q1 FY2023 | Mar 31, 2023 | $36.66M | +18.2% |
| Q4 FY2022 | Dec 31, 2022 | $36.16M | +14.7% |
| Q3 FY2022 | Sep 30, 2022 | $36.96M | +18.4% |
| Q2 FY2022 | Jun 30, 2022 | $34.45M | +2.6% |
| Q1 FY2022 | Mar 31, 2022 | $31.01M | -0.1% |
| Q4 FY2021 | Dec 31, 2021 | $31.54M | -2.9% |
| Q3 FY2021 | Sep 30, 2021 | $31.20M | -6.7% |
| Q2 FY2021 | Jun 30, 2021 | $33.58M | +51.8% |
| Q1 FY2021 | Mar 31, 2021 | $31.04M | +27.9% |
| Q4 FY2020 | Dec 31, 2020 | $32.50M | +15.4% |
| Q3 FY2020 | Sep 30, 2020 | $33.43M | +17.0% |
| Q2 FY2020 | Jun 30, 2020 | $22.12M | -17.2% |
| Q1 FY2020 | Mar 31, 2020 | $24.26M | +4.2% |
| Q4 FY2019 | Dec 31, 2019 | $28.16M | +20.2% |
| Q3 FY2019 | Sep 30, 2019 | $28.56M | +26.1% |
| Q2 FY2019 | Jun 30, 2019 | $26.70M | +29.7% |
| Q1 FY2019 | Mar 31, 2019 | $23.29M | +34.9% |
| Q4 FY2018 | Dec 31, 2018 | $23.43M | +38.1% |
| Q3 FY2018 | Sep 30, 2018 | $22.66M | +41.2% |
| Q2 FY2018 | Jun 30, 2018 | $20.58M | +35.7% |
| Q1 FY2018 | Mar 31, 2018 | $17.26M | +41.0% |
| Q4 FY2017 | Dec 31, 2017 | $16.97M | +48.8% |
| Q3 FY2017 | Sep 30, 2017 | $16.05M | – |
| Q2 FY2017 | Jun 30, 2017 | $15.17M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.41M | – |
See a number that looks wrong?